{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:07:43Z","timestamp":1793070463133,"version":"4.5.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5980-y","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T12:03:45Z","timestamp":1564747425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acquired immunodeficiency associated with thymoma: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Takahisa","family":"Kawamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4047-2929","authenticated-orcid":false,"given":"Tateaki","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Wakuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Kenmotsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyasu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"5980_CR1","first-page":"1","volume":"26","author":"RA Good","year":"1954","unstructured":"Good RA. Agammaglobulinaemia-a provocative experiment of nature. Bulletin of the University of Minnesota. 1954;26:1\u201319.","journal-title":"Bulletin of the University of Minnesota"},{"issue":"6","key":"5980_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00277-003-0635-z","volume":"82","author":"L Montella","year":"2003","unstructured":"Montella L, Masci AM, Merkabaoui G, Perna F, Vitiello L, Racioppi L, Palmieri G. B-cell lymphopenia and hypogammaglobulinemia in thymoma patients. Ann Hematol. 2003;82(6):343\u20137.","journal-title":"Ann Hematol"},{"issue":"6","key":"5980_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/76233","volume":"6","author":"K Oritani","year":"2000","unstructured":"Oritani K, Medina KL, Tomiyama Y, Ishikawa J, Okajima Y, Ogawa M, Yokota T, Aoyama K, Takahashi I, Kincade PW, et al. Limitin: an interferon-like cytokine that preferentially influences B-lymphocyte precursors. Nat Med. 2000;6(6):659\u201366.","journal-title":"Nat Med"},{"issue":"11","key":"5980_CR4","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1111\/j.1572-0241.2000.03285.x","volume":"95","author":"SA Call","year":"2000","unstructured":"Call SA, Heudebert G, Saag M, Wilcox CM. The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells\/mm3. Am J Gastroenterol. 2000;95(11):3142\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"5980_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00005792-200103000-00005","volume":"80","author":"PE Tarr","year":"2001","unstructured":"Tarr PE, Sneller MC, Mechanic LJ, Economides A, Eger CM, Strober W, Cunningham-Rundles C, Lucey DR. Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore). 2001;80(2):123\u201333.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"5980_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jcp.56.1.12","volume":"56","author":"P Kelleher","year":"2003","unstructured":"Kelleher P, Misbah SA. What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol. 2003;56(1):12\u20136.","journal-title":"J Clin Pathol"},{"issue":"12","key":"5980_CR7","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood.V96.12.3872","volume":"96","author":"V Hoffacker","year":"2000","unstructured":"Hoffacker V, Schultz A, Tiesinga JJ, Gold R, Schalke B, Nix W, Kiefer R, Muller-Hermelink HK, Marx A. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood. 2000;96(12):3872\u20139.","journal-title":"Blood"},{"issue":"3","key":"5980_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1056\/NEJM199501193320303","volume":"332","author":"CL Mackall","year":"1995","unstructured":"Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT, Steinberg SM, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 1995;332(3):143\u20139.","journal-title":"N Engl J Med"},{"issue":"8","key":"5980_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/1752-1947-8-457","volume":"21","author":"JL Wickemeyer","year":"2014","unstructured":"Wickemeyer JL, Sekhsaria S. Prolonged severe immunodeficiency following thymectomy and radiation: a case report. J Med Case Rep. 2014;21(8):457.","journal-title":"J Med Case Rep"},{"issue":"3","key":"5980_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s10875-011-9644-1","volume":"32","author":"MR Khawaja","year":"2012","unstructured":"Khawaja MR, Nelson RP Jr, Miller N, Badve SS, Loehrer E, Czader M, Perkins SM, Kesler K, Loehrer PJ Sr. Immune-mediated diseases and immunodeficiencies associated with thymic epithelial neoplasms. J Clin Immunol. 2012;32(3):430\u20137.","journal-title":"J Clin Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5980-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5980-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5980-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T08:43:31Z","timestamp":1596271411000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5980-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5980"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5980-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable as this is not an interventional study. The need for approval was waived by the Shizuoka Cancer Center Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication was obtained from the patient described and is available for review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"H.K. has received honoraria from Eli Lilly Japan K.K. and Taiho Pharmaceutical Co. Ltd. K.N. has received honoraria from Chugai Pharmaceutical Co. Ltd., Novartis Pharma K.K., and Taiho Pharmaceutical Co. Ltd. S.O. has received honoraria from Chugai Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., AstraZeneca K.K., Boehringer Ingelheim Japan Inc., Taiho Pharmaceutical Co. Ltd., and MSD K.K. K.W. has received honoraria from Eli Lilly Japan K.K., Chugai Pharmaceutical Co. Ltd., Taiho Pharmaceutical Co. Ltd., Boehringer Ingelheim Japan Inc., Ono Pharmaceutical Co. Ltd., and MSD K.K. A.O. has received honoraria from Chugai Pharmaceutical Co. Ltd., Novartis Pharma K.K., Ono Pharmaceutical Co. Ltd., Bristol-Myers Squibb Co. Ltd., and Taiho Pharmaceutical Co. Ltd.; and research funding from Chugai Pharmaceutical Co. Ltd. and Taiho Pharmaceutical Co. Ltd. H.K. has received honoraria from Eli Lilly Japan K.K., Chugai Pharmaceutical Co. Ltd., AstraZeneca K.K., Ono Pharmaceutical Co. Ltd., Boehringer Ingelheim Japan Inc., Novartis Pharma K.K., Bristol-Myers Squibb Co. Ltd., Kyowa Hakko Kirin Co. Ltd., and MSD K.K.; and research funding from AstraZeneca K.K., Chugai Pharmaceutical Co. Ltd. and Boehringer Ingelheim Japan Inc. H.M. has received honoraria from AstraZeneca K.K., Eli Lilly Japan K.K., Chugai Pharmaceutical Co. Ltd., Boehringer Ingelheim Japan Inc., Pfizer Inc., Taiho Pharmaceutical Co. Ltd., Novartis Pharma K.K., Bristol-Myers Squibb Co. Ltd., and Ono Pharmaceutical Co. Ltd. T.T. has received grants and honoraria from Ono Pharmaceutical Co. Ltd., MSD K.K., AstraZeneca K.K., Eli Lilly Japan K.K., Chugai Pharmaceutical Co. Ltd.; grants from Pfizer Inc.; and honoraria from Boehringer Ingelheim Japan Inc., and Roche Diagnostics K.K. The remaining author declares no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"762"}}